Stellanie Krimm
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment, Estrogen and related hormone effects, Endometriosis Research and Treatment
Most-Cited Works
- → Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates(2013)488 cited
- → Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates(2015)148 cited
- → Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers(2022)57 cited
- → Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001(2018)52 cited
- → IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control(2025)35 cited
- → Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies(2016)33 cited
- → Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer(2018)11 cited
- → Abstract NT-090: PRECLINICAL ACTIVITY AND SAFETY OF STRO-002, A NOVEL ADC TARGETING FOLATE RECEPTOR ALPHA FOR OVARIAN AND ENDOMETRIAL CANCER(2019)9 cited
- → Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models(2016)4 cited
- → CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001(2017)1 cited